Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Thadani: Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy.... (0.11 sec) 

Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy …

- annals.org
U Thadani, CR Maranda, E Amsterdam, L … - Annals of internal medicine, 1994 - Am Coll Physicians
Objective: To determine whether isosorbide-5-mononitrate (IS-5-MN), an active
metabolite of isosorbide dinitrate, when given twice daily (in the morning and 7
hours later), prevents development of tolerance and reduction in exercise ...
Cited by 49 - Related articles - All 6 versions

Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina …


SG Chrysant, SP Glasser, N Bittar, FE Shahidi, … - The American journal of cardiology, 1993 - ncbi.nlm.nih.gov
1: Am J Cardiol. 1993 Dec 1;72(17):1249-56. Efficacy and safety of extended-release
isosorbide mononitrate for stable effort angina pectoris. ...
Cited by 50 - Related articles - BL Direct - All 2 versions

Eccentric dosing with isosorbide-5-mononitrate in angina pectoris.


JO Parker - The American journal of cardiology, 1993 - ncbi.nlm.nih.gov
In a placebo-controlled, parallel, double-blind study, 214 patients with stable
angina were studied. Doses of 5, 10 and 20 mg of immediate-release
isosorbide-5-mononitrate (IS-5-MN) or placebo were administered at 0800 and ...
Cited by 39 - Related articles - BL Direct - All 2 versions

Short and long-acting oral nitrates for stable angina pectoris


U Thadani, RJ Lipicky - Cardiovascular Drugs and Therapy, 1994 - Springer
Summary. Nitroglycerin (NTG) spray and sublingual tablets rapidly relieve an
established attack of angina, and their in- frequent use is not associated with
the development of toler- ance. Although, following a suitable nitrate-free ...
Cited by 23 - Related articles - BL Direct - All 3 versions

Induction and circumvention of nitrate tolerance applying different dosage intervals* 1

- sigmund-silber.com [PDF] 
S Silber, AC Vogler, KH Krause, M Vogel, K … - The American journal of medicine, 1987 - Elsevier
There is increasing evidence that constant nitrate plasma levels, as induced by
at least three-times-daily ingestions of isosorbide dinitrate in
sustained-release form, lead to an attenuation or even complete loss of the ...
Cited by 36 - Related articles - All 8 versions

Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina


H DeMots, SP Glasser - Journal of the American College of Cardiology, 1989 - Am Coll Cardio Found
The effectiveness of an intermittent regimen of transdermal nitroglycerin in
chronic stable angina was evaluated in 206 patients using serial treadmill
testing. After a placebo stabilization phase, patients were randomized to 4 ...
Cited by 103 - Related articles - All 3 versions

Intermittent transdermal nitroglycerin therapy: decreased anginal threshold during the nitrate- …

- ahajournals.org
JD Parker, AB Parker, B Farrell, JO Parker - Circulation, 1995 - Am Heart Assoc
Methods and Results Twelve patients with stable angina were enrolled in a
randomized, double-blind, placebo-controlled, crossover study. These patients
had reproducible treadmill walking times and were taking no other ...
Cited by 36 - Related articles - BL Direct - All 4 versions

Intermittent transdermal nitroglycerin therapy in angina pectoris: clinically effective without …

- ahajournals.org
JO Parker, MH Amies, RW Hawkinson, JM … - Circulation, 1995 - Am Heart Assoc
Background The objectives of this study were to assess the antianginal and
anti-ischemic effects of three dose levels of transdermal nitroglycerin patches
applied for 12 hours daily for 30 days. The study also assessed the ...
Cited by 39 - Related articles - BL Direct - All 4 versions

Ointments and transdermal nitroglycerin patches for stable angina pectoris


U Thadani, RJ Lipicky - Cardiovascular Drugs and Therapy, 1994 - Springer
Nitrates have been used by the transcutaneous route in the form of nitroglycerin
(NTG) ointment for almost 50 years to treat patients with ischemic heart dis-
ease [1,2]. Transcutaneous administration of' nitrates avoids first-pass ...
Cited by 15 - Related articles - BL Direct - All 3 versions

Absence of pre-dose rebound phenomena with once daily 5-ISMN in a controlled-release …


G Olsson, J Allgen, O Amtorp, G Nyberg, JO … - European heart journal, 1992 - Eur Soc Cardiology
*Cardiovascular Medicine, Astra Hassle AB, S-431 83 Molndal, Sweden; ^Department
ofCardiology, Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark;
%Division of Cardiology, Queen's University, Kingston, Ontario, Canada
Cited by 19 - Related articles - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google